Strategy Doctor Limited - Accounts to registrar (filleted) - small 23.2.5

Strategy Doctor Limited - Accounts to registrar (filleted) - small 23.2.5


IRIS Accounts Production v23.2.0.158 12391479 director 1.2.22 31.1.23 31.1.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh123914792022-01-31123914792023-01-31123914792022-02-012023-01-31123914792021-01-31123914792021-02-012022-01-31123914792022-01-3112391479ns10:Originalns15:EnglandWales2022-02-012023-01-3112391479ns14:PoundSterlingns10:Original2022-02-012023-01-3112391479ns10:Originalns10:Director12022-02-012023-01-3112391479ns10:Original2022-02-012023-01-3112391479ns10:Original2023-01-3112391479ns10:Originalns10:PrivateLimitedCompanyLtd2022-02-012023-01-3112391479ns10:Originalns10:SmallEntities2022-02-012023-01-3112391479ns10:Originalns10:AuditExempt-NoAccountantsReport2022-02-012023-01-3112391479ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-02-012023-01-3112391479ns10:SmallCompaniesRegimeForAccountsns10:Original2022-02-012023-01-3112391479ns10:Originalns10:FullAccounts2022-02-012023-01-3112391479ns10:Originalns10:RegisteredOffice2022-02-012023-01-3112391479ns10:Original2022-01-3112391479ns10:Originalns5:CurrentFinancialInstruments2023-01-3112391479ns10:Originalns5:CurrentFinancialInstruments2022-01-3112391479ns5:ShareCapitalns10:Original2023-01-3112391479ns5:ShareCapitalns10:Original2022-01-3112391479ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-01-3112391479ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-01-3112391479ns10:Originalns5:PlantMachinery2022-02-012023-01-3112391479ns10:Original2021-02-012022-01-3112391479ns10:Originalns5:PlantMachinery2022-01-3112391479ns10:Originalns5:PlantMachinery2023-01-3112391479ns10:Originalns5:PlantMachinery2022-01-3112391479ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-01-3112391479ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-01-31
REGISTERED NUMBER: 12391479 (England and Wales)












Unaudited Financial Statements

for the Year Ended 31 January 2023

for

Strategy Doctor Limited

Strategy Doctor Limited (Registered number: 12391479)






Contents of the Financial Statements
for the Year Ended 31 January 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Strategy Doctor Limited

Company Information
for the Year Ended 31 January 2023







DIRECTOR: Dr N J Bye





REGISTERED OFFICE: 18 Salisbury Road
Bath
BA1 6QZ





REGISTERED NUMBER: 12391479 (England and Wales)





ACCOUNTANTS: Wormald & Partners
Chartered Accountants (ICAEW)
Redland House
157 Redland Road
Redland
Bristol
BS6 6YE

Strategy Doctor Limited (Registered number: 12391479)

Balance Sheet
31 January 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 347 251

CURRENT ASSETS
Debtors 5 11,374 4,180
Cash at bank 29,843 17,711
41,217 21,891
CREDITORS
Amounts falling due within one year 6 13,655 12,134
NET CURRENT ASSETS 27,562 9,757
TOTAL ASSETS LESS CURRENT
LIABILITIES

27,909

10,008

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings 27,908 10,007
SHAREHOLDERS' FUNDS 27,909 10,008

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 10 October 2023 and were signed by:





Dr N J Bye - Director


Strategy Doctor Limited (Registered number: 12391479)

Notes to the Financial Statements
for the Year Ended 31 January 2023

1. STATUTORY INFORMATION

Strategy Doctor Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33.33% on reducing balance basis

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

Strategy Doctor Limited (Registered number: 12391479)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2023

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 February 2022 565
Additions 269
At 31 January 2023 834
DEPRECIATION
At 1 February 2022 314
Charge for year 173
At 31 January 2023 487
NET BOOK VALUE
At 31 January 2023 347
At 31 January 2022 251

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 9,821 3,635
Other debtors 1,553 545
11,374 4,180

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Taxation and social security 7,960 2,557
Other creditors 5,695 9,577
13,655 12,134